Literature DB >> 1681207

Reversion from zidovudine resistance to sensitivity on cessation of treatment.

S Land, K McGavin, C Birch, R Lucas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1681207     DOI: 10.1016/0140-6736(91)90727-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Zidovudine: a review of pharmacoeconomic and quality-of-life considerations for its use in patients with human immunodeficiency virus.

Authors:  H D Langtry; K J Palmer; P Benfield
Journal:  Pharmacoeconomics       Date:  1993-04       Impact factor: 4.981

2.  Effects of discontinuation of zidovudine treatment on zidovudine sensitivity of human immunodeficiency virus type 1 isolates.

Authors:  C A Boucher; R van Leeuwen; P Kellam; P Schipper; J Tijnagel; J M Lange; B A Larder
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

Review 3.  Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  Michelle I Wilde; Heather D Langtry
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

4.  Demonstration of sustained drug-resistant human immunodeficiency virus type 1 lineages circulating among treatment-naïve individuals.

Authors:  Stéphane Hué; Robert J Gifford; David Dunn; Esther Fernhill; Deenan Pillay
Journal:  J Virol       Date:  2009-01-21       Impact factor: 5.103

Review 5.  Resistance against Integrase Strand Transfer Inhibitors and Relevance to HIV Persistence.

Authors:  Thibault Mesplède; Mark A Wainberg
Journal:  Viruses       Date:  2015-07-07       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.